• ABOUT US
  • TECHNOLOGY
  • BUSINESS
  • R&D
  • IR
  • PR
  • RECRUIT
  • ENG
  • KOR

ABOUT US

  • Greeting from the CEO
  • Vision & Mission
  • History
  • Partners

TECHNOLOGY

  • Core Technology
  • Multi-Omics
  • Microbiome
  • Metabolome

BUSINESS

  • Personalized Analysis Service
  • Health Functional Food
  • CDMO(GMP)

R&D

  • Research Institute
  • Patents and Papers
  • Pharmabiotic(LBP)
  • Pipeline

IR

  • Announcements
  • Inquiries and Suggestions

PR

  • Notice
  • Media

RECRUIT

  • Talents
  • Welfare
  • Employment Notice
  • Employment FAQ
  • PMAS
  • MBR
  • Multi-Omics Research
  • NGS
  • Analysis of Metabolome
  • Management of Microbial Resource
  • Research on Development of New Drugs

A microbiome healthcare company serving the value of healthy life

  • ABOUT US
    • Greeting from the CEO
    • Vision & Mission
    • History
    • Partners
  • TECHNOLOGY
    • Core Technology
      • PMAS
      • MBR
    • Multi-Omics
      • Multi-Omics Research
    • Microbiome
      • NGS
    • Metabolome
      • Analysis of Metabolome
  • BUSINESS
    • Personalized Analysis Service
    • Health Functional Food
    • CDMO(GMP)
  • R&D
    • Research Institute
    • Patents and Papers
    • Pharmabiotic(LBP)
      • Management of Microbial Resource
      • Research on Development of New Drugs
    • Pipeline
  • IR
    • Announcements
    • Inquiries and Suggestions
  • PR
    • Notice
    • Media
  • RECRUIT
    • Talents
    • Welfare
    • Employment Notice
    • Employment FAQ
  • 카카오톡
  • 네이버 블로그
  • 네이버 쇼핑
  • 인스타그램
  • 유튜브

A microbiome healthcare company serving the value of healthy life

  • ABOUT US
    • Greeting from the CEO
    • Vision & Mission
    • History
    • Partners
  • TECHNOLOGY
    • Core Technology
      • PMAS
      • MBR
    • Multi-Omics
      • Multi-Omics Research
    • Microbiome
      • NGS
    • Metabolome
      • Analysis of Metabolome
  • BUSINESS
    • Personalized Analysis Service
    • Health Functional Food
    • CDMO(GMP)
  • R&D
    • Research Institute
    • Patents and Papers
    • Pharmabiotic(LBP)
      • Management of Microbial Resource
      • Research on Development of New Drugs
    • Pipeline
  • IR
    • Announcements
    • Inquiries and Suggestions
  • PR
    • Notice
    • Media
  • RECRUIT
    • Talents
    • Welfare
    • Employment Notice
    • Employment FAQ
  • 카카오톡
  • 네이버 블로그
  • 네이버 쇼핑
  • 인스타그램
  • 유튜브

PR

  • home
  • PR
    • ABOUT US
    • TECHNOLOGY
    • BUSINESS
    • R&D
    • IR
    • PR
    • RECRUIT
  • Media
    • Notice
    • Media

Media

  • HEM Pharma begins full-fledged KOSDAQ listing...submits stock report
    2024.07.08
  • HEM Pharma Approves Preliminary Review of KOSDAQ Listing...Promoting IPO Full-Sc..
    2024.06.11
  • Amway signs joint research agreement with HEM Pharma
    2024.02.29
  • HEM Pharma promotes ‘Profitable Growth’ in 2024
    2024.01.05
  • HEM Pharma submits preliminary review application for KOSDAQ listing
    2023.12.18
  • CEO of HEM Pharma receives ‘2023 Bio Industry Day’ award from Ministry of Trade,..
    2023.12.01
  • HEM Pharma completes paid-in capital increase of KRW 5 billion
    2023.11.23
  • HEM Pharma passes technology evaluation for special technology listing
    2023.09.04
  • [Analysis of HEM Pharma] ③ New drug developers making money… "ROI within 5 ..
    2023.08.16
  • [Analysis of HEM Pharma] ② As a game changer in the '11 trillion won' customized..
    2023.08.16
  • [Analysis of HEM Pharma] ① Founded by the best authority on microbiome
    2023.08.16
  • HEM Pharma and Genome & Company collaborate to develop new microbiome drugs
    2023.08.11
1 2 3 4 5
Pohang
Address. 102, Business incubator center, Handong Global University, 558, Handong-ro, Heunghae-eup, Buk-gu, Pohang-si, Gyeongsangbuk-do, Republic of Korea
Gwanggyo
Address. 404, Ace Gwanggyo Tower 3, 77, Changnyong-daero 256-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea
(C) 2022.HEM Pharma Inc. All rights reserved.